Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16
Revenue
21,840.00 20,178.00 19,372.00 18,870.00 19,131.00 16,074.00 17,290.00 15,983.00 12,093.00 12,483.00
Revenue Growth
8.24% 4.16% 2.66% (1.36%) 19.02% (7.03%) 8.18% 32.17% (3.12%) 21.41%
Gross Profit
9,925.00 9,125.00 8,170.00 8,477.00 8,631.00 6,798.00 8,288.00 7,269.00 5,965.00 5,991.00
Operating Income
2,578.00 2,398.00 2,111.00 2,283.00 2,251.00 912.00 1,760.00 1,509.00 1,522.00 1,430.00
EBT
1,881.00 2,005.00 1,662.00 1,783.00 1,692.00 414.00 1,176.00 1,173.00 976.00 1,074.00
Income after Tax
1,678.00 1,705.00 1,530.00 1,635.00 1,604.00 352.00 1,233.00 311.00 1,100.00 977.00
Net Income Common
1,678.00 1,705.00 1,424.00 1,689.00 2,002.00 767.00 1,082.00 159.00 1,030.00 976.00
EPS (Diluted)
5.82 5.93 4.94 5.88 6.85 2.71 3.89 0.60 4.60 4.49
Shares (Diluted, Weighted)
288.51 291.01 288.39 287.36 292.09 282.40 274.78 264.62 223.59 217.54
Gross Margin
45.44% 45.22% 42.17% 44.92% 45.12% 42.29% 47.94% 45.48% 49.33% 47.99%
EBIT Margin
11.80% 11.88% 10.90% 12.10% 11.77% 5.67% 10.18% 9.44% 12.59% 11.46%
Net Profit Margin
7.68% 8.45% 7.35% 8.95% 10.46% 4.77% 6.26% 0.99% 8.52% 7.82%
Free Cash Flow Margin
12.23% 15.46% 10.92% 7.94% 15.33% 13.49% 13.72% 12.33% 15.07% 14.95%
EBITDA
5,040.00 4,684.00 4,399.00 4,512.00 4,481.00 3,027.00 4,013.00 3,487.00 2,610.00 2,544.00
EBIT
2,578.00 2,398.00 2,111.00 2,283.00 2,251.00 912.00 1,760.00 1,509.00 1,522.00 1,430.00

Show all line items

In millions of $ except per-share values · columns are period end dates